ID   Ff-I14s04 ABII KO #13
AC   CVCL_C1FD
SY   Ff-I14s04-AB II-KO-13; 21B78
DR   Wikidata; Q114311400
RX   PubMed=35755947;
WW   https://www.cira-foundation.or.jp/assets/file/genome-edited/E_Ff-I14s04-ABII-KO-13.pdf
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 7067; CIITA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 4931; HLA-A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 4932; HLA-B.
CC   Omics: Genome sequenced.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1DM ! Ff-I14s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
RX   PubMed=35755947; DOI=10.1016/j.omtm.2022.05.010;
RA   Kitano Y., Nishimura S., Kato T.M., Ueda A., Takigawa K., Umekage M.,
RA   Nomura M., Kawakami A., Ogawa H., Xu H.-G., Hotta A., Takasu N.,
RA   Tsukahara M.;
RT   "Generation of hypoimmunogenic induced pluripotent stem cells by
RT   CRISPR-Cas9 system and detailed evaluation for clinical application.";
RL   Mol. Ther. Methods Clin. Dev. 26:15-25(2022).
//